Stephen Blakeston's headaches and jumbled speech were dismissed as "stress" as the dad of two was told he was faking it.

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

GBM 是一种极具侵袭性的脑癌，当前治疗手段效果不佳。标准治疗药物替莫唑胺（TMZ）联合放疗，患者中位生存期仅 15 个月，5 年生存率仅 5%。贝伐单抗、厄洛替尼、吉非替尼及免疫检查点抑制剂等治疗方案，也未能显著改善患者生存状况。治疗失败的关键原因在于肿瘤内高度异质性（ITH）和细胞可塑性。ITH 方面，已有研究通过多种方法对 GBM ...

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...

Dr Rashida Karmali, a Uganda-born cancer scientist based in New York, has developed a groundbreaking drug, ...

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

The University of Southern California (USC) has received a $6m grant from the California Institute for Regenerative Medicine ...